Showing results (1-10 of 159) with videos related to
Sort By:
Pageof 16
Frontiers in Oncology|July 19, 2019
Leveraging National Cancer Institute Programmatic Collaboration for Single Radiopharmaceutical Drug Master FilesCharles A Kunos, Jacek Capala, Susan Percy IvyFrontiers in Oncology|March 13, 2019
Radiopharmaceuticals for Relapsed or Refractory LeukemiasCharles A Kunos, Jacek Capala, Susan Percy IvyFrontiers in Oncology|July 13, 2019
Radiopharmaceuticals for Persistent or Recurrent Uterine Cervix CancerCharles A Kunos, Jacek Capala, Elise C Kohn, et al.Frontiers in Oncology|April 16, 2019
Radiopharmaceuticals for Relapsed or Refractory Ovarian CancersCharles A Kunos, Jacek Capala, Shanda Finnigan, et al.Frontiers in Oncology|October 26, 2019
Clinical Outcome Assessments Toolbox for RadiopharmaceuticalsCharles A Kunos, Jacek Capala, Adam P Dicker, et al.American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|September 21, 2018
National Cancer Institute Programmatic Collaboration for Investigational RadiopharmaceuticalsCharles A Kunos, Jacek CapalaPharmaceuticals (Basel, Switzerland)|October 3, 2020
Radiopharmaceutical Switch Maintenance for Relapsed Ovarian CarcinomaCharles A Kunos, Jacek CapalaClinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 4, 2020
A New Generation of "Magic Bullets" for Molecular Targeting of CancerJacek Capala, Charles A KunosFrontiers in Oncology|October 5, 2020
Phase 0 Radiopharmaceutical-Agent Clinical DevelopmentCharles A Kunos, Larry V Rubinstein, Jacek Capala, et al.Frontiers in Oncology|April 20, 2017
Phase I Trial of Triapine-Cisplatin-Paclitaxel Chemotherapy for Advanced Stage or Metastatic Solid Tumor CancersCharles A Kunos, Edward Chu, Della Makower, et al.Pageof 16